![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Smit Jan WA Diamant Michaela
Publisher: Future Medicine
ISSN: 1462-2416
Source: Pharmacogenomics, Vol.5, Iss.3, 2004-04, pp. : 295-304
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Genetically defined pancreatic beta cell failure
By Smit Jan WA Diamant Michaela
Pharmacogenomics, Vol. 3, Iss. 5, 2002-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drug Treatment of Combined Hyperlipidemia
American Journal of Cardiovascular Drugs, Vol. 1, Iss. 5, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs for hyperlipidemia
By Paras Christos Hussain M Mahmood Rosenson Robert S
Expert Opinion on Emerging Drugs, Vol. 15, Iss. 3, 2010-09 ,pp. :